Altimmune (ALT) FCF Margin (2010 - 2025)

Altimmune (ALT) has reported FCF Margin for 16 consecutive years, with 74803.85% the latest figure, recorded in Q4 2025.

• In Q4 2025, FCF Margin rose 29049615.0% year-over-year to 74803.85%; the TTM figure through Dec 2025 stood at 164721.95% (up 23451805.0% YoY), while the FY2025 annual figure was 164746.34%, up 23449366.0% from the prior year.
• FCF Margin advanced to 74803.85% in Q4 2025 per ALT's latest filing, from 237940.0% in the prior quarter.
• Across five years, FCF Margin topped out at 674.82% in Q4 2021 and bottomed at 755500.0% in Q3 2022.
• Historically, FCF Margin has averaged 210363.27% across 5 years, with a median of 150847.32% in 2023.
• Annual changes were most pronounced in 2022 — FCF Margin tumbled 74420570 bps — and 2023, when it soared 74984061 bps.
• Altimmune's FCF Margin stood at 674.82% in 2021, then sank by 9785 bps to 66707.69% in 2022, then jumped by 33 bps to 44683.78% in 2023, then tumbled by 718 bps to 365300.0% in 2024, then surged by 80 bps to 74803.85% in 2025.
• Business Quant data shows ALT's FCF Margin at 74803.85% in Q4 2025, 237940.0% in Q3 2025, and 387000.0% in Q2 2025.